News
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from customers using ancestry testing and other services.
D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy ...
Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.
More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...
PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...
Lawmakers want to know what will be done to make sure the data will stay out of the hands of adversaries like China.
Bankrupt DNA testing company 23andMe Holding (OTC:MEHCQ) is set to hold a second auction to sell its assets, including ...
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback